Table 3.
Name | Accession noa. | Disease phenotype | Regulation | Mechanism | Refs |
---|---|---|---|---|---|
APF | GEO profile: AK079427 | myocardial infarction | upregulate | Binds MIR188–3p to affect ATG7 expression | 104 |
TGFB2-OT1 (FLJ11812) | HGNC_ID: 50629 | inflammation | — | Binds MIR3960, MIR4488 and MIR4459 to target ATG13, CERS1, NAT8L and LARP1 | 39,222 |
PTENP1 | HGNC_ID: 9589 | hepatocellular carcinoma | downregulate | Represses oncogenic PI3K-AKT signaling pathway and elicit autophagy via sequestering MIR17, MIR19B and MIR20Ain vitro | 97 |
NBR2 | HGNC_ID: 20691 | human cancers | downregulate | Induced by the STK11-AMPK pathway under energy stress and interacts with AMPK to promotes kinase activity in turn | 223,224 |
PVT1 | HGNC_ID: 9709 | diabetes | upregulate | unknown | 225 |
MEG3 | HGNC_ID: 14575 | mycobacterial infection bladder cancer | downregulate | Linked to MTOR activity and PI3K-AKT signaling pathway to regulate autophagy | 99,226 |
PCGEM1 | HGNC_ID: 30145 | osteoarthritis | upregulate | Increases the expression of ATG12, ATG5, ATG3 and BECN1 | 227 |
BANCR | HGNC_ID: 43877 | papillary thyroid carcinoma | upregulate | unknown | 228 |
GAS5 | HGNC_ID: 16355 | osteoarthritis non-small cell lung cancer | upregulate | Acts as a negative regulator of MIR21 in autophagy | 229,230 |
Chast | Ensembl_ID: ENSMUST00000130556 | cardiovascular | downregulate | Impedes Plekhm1 to autophagy inhibition and cardiomyocyte hypertrophy | 101 |
H19 | HGNC_ID:4713 | diabetic cardiomyopathy | downregulate | Regulates DIRAS3 expression and promote MTOR phosphorylation to inhibit autophagy as cardiomyocytes exposed to high glucose | 231 |
loc146880 | HGNC_ID:28630 | lung cancer | upregulate | PM2.5 exposure induces ROS, which activates loc146880 expression, and the lncRNA upregulates autophagy in return | 232 |
HOTAIRM1 | HGNC_ID: 37117 | myeloid differentiation | upregulate | Acts as a miRNA sponge in a pathway that included MIR20A, MIR106B, MIR125B and their targets ULK1, E2F1 and DRAM2. | 233 |
AlncRNA | — | hepatocellular carcinoma | upregulate | Targets multiple miRNAs including MIR21, MIR153, MIR216A, MIR217, MIR494 and MIR10A-5p | 234 |
MALAT1 | HGNC_ID:29665 | hepatocellular carcinoma aggressive pancreatic cancer | upregulate | EPAS1/HIF-2α-MALAT1-MIR216B axis regulating MDR of HCC cells via modulating autophagy in hepatocellular carcinoma and via HuR-TIA-1-mediated autophagy activation in aggressive pancreatic cancer | 235,236 |
AK156230 | GEO profile: AK156230 | mouse embryonic fibroblasts | upregulate | unknown | 237 |
HOTAIR | HGNC_ID: 33510 | hepatocellular carcinoma | upregulate | Activates autophagy by increasing ATG3 and ATG7 expression | 238 |
HNF1A-AS1 | HGNC_ID: 26785 | hepatocellular carcinoma | upregulate | Acts as an oncogene in tumor growth and apoptosis through sponging tumor-suppressive MIR30B-5p (MIR30B) and derepress BCL2 | 207 |
Ensembl Genome Browser, Gene Expression Omnibus (GEO), HUGO Gene Nomenclature Committee (HGNC)